Clinical Study of Lung-benefiting Moxibustion Reduce Exacerbations of Asthma

For patients with poor asthma control, on the basis of treatment guided by GINA guidelines, lung-benefiting moxibustion treatment will be given, and it will be applied 10 days before "early onset", once every 10 days, and the follow-up was 45 weeks, 1 cycle per year, for 2 consecutive cycles (2 years). The annual number of flare-up of asthma patients will be used as the main outcome index to evaluate the clinical effect of lung-benefiting moxibustion on reducing exacerbations of asthma. By observing immunoglobulin, T cell subsets and other indicators, the advantage population and mechanism of moxibustion in treating patients with poor asthma control will be clarified.

NCT Number	NCT06777472
Lead Sponsor	Cuiling Feng Collaborators: The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhuhai Hospital of Integrated Traditional Chinese and Western Medicine
Conditions	Asthma
Enrollment	384 participants
Start Date	2025-07
Primary Completion	2026-09 (estimated)
Study Completion	2027-08 (estimated)
Updated on ClinicalTrials.gov	2025-01-15